Abstract | OBJECTIVE: STUDY DESIGN: We conducted a retrospective study of preterm infants admitted to Canadian Neonatal Network units between 2010 and 2018. Infants were classified into 2 groups based on receipt of antenatal steroids; the latter subgrouped as recent (≤7 days before birth) or latent (>7 days before birth) exposures. The co-exposure was prophylactic indomethacin. The primary outcome was SIP. Multivariable logistic regression analysis was used to calculate aORs. RESULTS: Among 4720 eligible infants, 4121 (87%) received antenatal steroids and 1045 (22.1%) received prophylactic indomethacin. Among infants exposed to antenatal steroids, those who received prophylactic indomethacin had higher odds of SIP (aOR 1.61, 95% CI 1.14-2.28) compared with no prophylactic indomethacin. Subgroup analyses revealed recent antenatal steroids exposure with prophylactic indomethacin had higher odds of SIP (aOR 1.67, 95% CI 1.15-2.43), but latent antenatal steroids exposure with prophylactic indomethacin did not (aOR 1.24, 95% CI 0.48-3.21), compared with the respective groups with no prophylactic indomethacin. Among those not exposed to antenatal steroids, mortality was lower among those who received prophylactic indomethacin (aOR 0.45, 95% CI 0.28-0.73) compared with no prophylactic indomethacin. CONCLUSIONS: In preterm neonates of <26 weeks of gestation or birth weight <750 g, co-exposure of antenatal steroids and prophylactic indomethacin was associated with SIP, especially if antenatal steroids was received within 7 days before birth. Among those unexposed to antenatal steroids, prophylactic indomethacin was associated with lower odds of mortality.
|
Authors | Hemasree Kandraju, Jaideep Kanungo, Kyong-Soon Lee, Sibasis Daspal, Mohammad Amin Adie, Jon Dorling, Xiang Y Ye, Shoo K Lee, Prakesh S Shah, Canadian Neonatal Network (CNN), Canadian Preterm Birth Network (CPTBN) Investigators |
Journal | The Journal of pediatrics
(J Pediatr)
Vol. 235
Pg. 34-41.e1
(08 2021)
ISSN: 1097-6833 [Electronic] United States |
PMID | 33741365
(Publication Type: Journal Article, Comment)
|
Copyright | Copyright © 2021 Elsevier Inc. All rights reserved. |
Chemical References |
|
Topics |
- Brain Injuries
- Canada
- Female
- Gestational Age
- Humans
- Indomethacin
(adverse effects)
- Infant
- Infant, Newborn
- Infant, Premature
- Intestinal Perforation
(chemically induced, epidemiology, prevention & control)
- Pregnancy
- Retrospective Studies
- Steroids
|